Table 1 Comparison of baseline characteristics between weaning success and weaning failure.
Variables | All | Weaning success | Weaning failure | p value |
---|---|---|---|---|
(n = 3695) | (n = 2274) | (n = 1421) | ||
Age (years) | 66.8 (55.4–77.5) | 67.3 (55.7–77.9) | 66.5 (54.6–76.4) | 0.052 |
Gender (male) | 2102 (56.9) | 1275 (56.1) | 827 (58.2) | 0.203 |
BMI (kg/m2) | 28.0 (24.2–33.3) | 27.6 (24.1–32.5) | 28.5 (24.5–34.0) | < 0.001 |
Smoking history | 315 (8.5) | 187 (8.2) | 128 (9.0) | 0.406 |
SAPS II | 43 (34–53) | 42 (33–52) | 44 (36–55) | < 0.001 |
SOFA | 7 (4–10) | 6 (4–9) | 8 (5–11) | < 0.001 |
Sources of admission | ||||
MICU | 871 (23.6) | 546 (24.0) | 325 (22.9) | 0.427 |
SICU | 609 (16.5) | 404 (17.8) | 205 (14.4) | 0.008 |
TSICU | 620 (16.8) | 371 (16.3) | 249 (17.5) | 0.339 |
MICU/SICU | 547 (14.8) | 328 (14.4) | 219 (15.4) | 0.411 |
CVICU | 465 (12.6) | 267 (11.7) | 198 (13.9) | 0.051 |
CCU | 359 (9.7) | 216 (9.5) | 143 (10.1) | 0.573 |
NSICU | 203 (5.5) | 129 (5.7) | 74 (5.2) | 0.546 |
Others | 21 (0.6) | 13 (0.6) | 8 (0.6) | 0.973 |
Comorbidities | ||||
Hypertension | 1479 (40.0) | 902 (39.7) | 577 (40.6) | 0.571 |
Diabetes mellitus | 1138 (30.8) | 685 (30.1) | 453 (31.9) | 0.261 |
COPD | 256 (6.9) | 157 (6.9) | 99 (7.0) | 0.942 |
Congestive heart failure | 1107 (30.0) | 675 (30.0) | 432 (30.4) | 0.643 |
Coronary artery disease | 1015 (27.5) | 620 (27.3) | 395 (27.8) | 0.724 |
Chronic kidney disease | 838 (22.7) | 513 (22.6) | 325 (22.9) | 0.826 |
Stroke | 733 (19.8) | 439 (19.3) | 294 (20.7) | 0.305 |
Parameters before SBT 4 h | ||||
VT (ml) | 451 (395–512) | 452 (392–519) | 451 (398–507) | 0.498 |
PEEP (cmH2O) | 5.0 (5.0–8.0) | 5.0 (5.0–5.3) | 6.0 (5.0–10.0) | < 0.001 |
Pplat (cmH2O) | 17.5 (15.0–20.5) | 17.0 (14.0–20.0) | 19.0 (16.0–22.0) | < 0.001 |
ΔP (cmH2O) | 11.3 (9.0–14.0) | 11.5 (9.0–14.0) | 11.0 (9.0–14.0) | 0.271 |
Ppeak (cmH2O) | 19.0 (15.0–24.0) | 17.0 (12.8–21.0) | 23.0 (19.0–27.0) | < 0.001 |
ΔPaw (cmH2O) | 13.0 (9.4–16.5) | 11.7 (8.0–15.5) | 15.0 (12.0–18.0) | < 0.001 |
RR (bpm) | 19 (16–22) | 18 (16–22) | 20 (17–24) | < 0.001 |
MV (l/min) | 8.2 (6.9–9.9) | 7.9 (6.7–9.5) | 8.8 (7.3–10.6) | < 0.001 |
FiO2 (%) | 40 (40–50) | 40 (40–50) | 40 (40–50) | < 0.001 |
MP (J/min) | 11.1 (7.4–16.2) | 9.2 (6.0–13.2) | 14.6 (10.6–20.2) | < 0.001 |
Cdyn (ml/cmH2O) | 33.9 (26.2–49.2) | 39.0 (28.5–62.0) | 29.6 (24.2–36.7) | < 0.001 |
Cdyn-MP (J/min × cmH2O/ml × 10–3) | 331.5 (163.9–563.6) | 231.5 (101.7–421.6) | 501.3 (323.4–744.8) | < 0.001 |
PBW-MP (J/min/kg) | 0.1881 (0.1234–0.2696) | 0.1520 (0.0995–0.2200) | 0.2452 (0.1837–0.3331) | < 0.001 |
RSBI (bpm/L) | 41.7 (32.6–53.7) | 40.2 (31.0–51.7) | 44.3 (35.1–56.5) | < 0.001 |
Laboratory data at the start of SBT | ||||
WBC (k/μl) | 11.5 (8.5–15.8) | 11.2 (8.3–15.3) | 11.9 (8.8–16.9) | < 0.001 |
PLT (k/μl) | 163 (109–228) | 162 (111–224) | 164 (108–233) | 0.502 |
Hb (g/dl) | 10.0 (8.6–11.5) | 9.9 (8.6–11.4) | 10.0 (8.6–11.6) | 0.282 |
Albumiun (g/dl) | 2.9 (2.5–3.4) | 3.0 (2.6–3.4) | 2.9 (2.4–3.4) | 0.013 |
SCr (mg/dl) | 1.1 (0.7–1.8) | 1.0 (0.7–1.7) | 1.2 (0.8–2.0) | < 0.001 |
Uorate before SBT (ml/kg/h) | 0.6 (0.4–1.1) | 0.7 (0.4–1.2) | 0.6 (0.3–1.1) | < 0.001 |
Physiological variables during SBT | ||||
HR (bpm) | 83 (72–97) | 82 (71–95) | 86 (73–99) | < 0.001 |
BF (bpm) | 19 (16–22) | 18 (15–21) | 20 (17–24) | < 0.001 |
MBP (mmHg) | 75 (68–84) | 76 (68–85) | 74 (67–83) | < 0.001 |
SPO2 (%) | 98 (97–100) | 99 (97–100) | 98 (96–100) | < 0.001 |
Temperature (℃) | 37.1 (36.8–37.5) | 37.1 (36.8–37.4) | 37.1 (36.8–37.6) | 0.024 |
PH (mmHg) | 7.39 (7.34–7.44) | 7.40 (7.35–7.44) | 7.38 (7.33–7.43) | < 0.001 |
PaO2 (mmHg) | 105 (84–130) | 106 (86–132) | 105 (83–129) | 0.331 |
PaCO2 (mmHg) | 39 (34–45) | 39 (34–44) | 39 (34–45) | 0.926 |
PF (mmHg) | 240 (180–323) | 253 (193–333) | 226 (163–305) | < 0.001 |